Morepen Laboratories Ltd banner

Morepen Laboratories Ltd
NSE:MOREPENLAB

Watchlist Manager
Morepen Laboratories Ltd Logo
Morepen Laboratories Ltd
NSE:MOREPENLAB
Watchlist
Price: 38.15 INR -2.75% Market Closed
Market Cap: ₹20.9B

Relative Value

The Relative Value of one MOREPENLAB stock under the Base Case scenario is hidden INR. Compared to the current market price of 38.15 INR, Morepen Laboratories Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MOREPENLAB Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

MOREPENLAB Competitors Multiples
Morepen Laboratories Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Morepen Laboratories Ltd
NSE:MOREPENLAB
20.9B INR 1.2 21.2 15.2 22.2
US
Eli Lilly and Co
NYSE:LLY
973.3B USD 16.4 52.8 35.5 38
US
Johnson & Johnson
NYSE:JNJ
572.1B USD 6.1 21.3 14.8 18.2
CH
Roche Holding AG
SIX:ROG
284.4B CHF 4.6 30.2 12.8 14.9
US
Merck & Co Inc
NYSE:MRK
302.3B USD 4.6 16.4 10.2 12
UK
AstraZeneca PLC
LSE:AZN
217.3B GBP 5.2 31.9 15.2 22.3
CH
Novartis AG
SIX:NOVN
227.3B CHF 5.2 20.3 12.8 16.5
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4 12.3 8.6 10
US
Pfizer Inc
NYSE:PFE
153.8B USD 2.5 19.7 7.4 9.8
US
Bristol-Myers Squibb Co
NYSE:BMY
119.5B USD 2.5 20.1 7.1 9.3
P/E Multiple
Earnings Growth PEG
IN
Morepen Laboratories Ltd
NSE:MOREPENLAB
Average P/E: 24.6
21.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
52.8
54%
1
US
Johnson & Johnson
NYSE:JNJ
21.3
6%
3.6
CH
Roche Holding AG
SIX:ROG
30.2
29%
1
US
Merck & Co Inc
NYSE:MRK
16.4
14%
1.2
UK
AstraZeneca PLC
LSE:AZN
31.9
38%
0.8
CH
Novartis AG
SIX:NOVN
20.3
17%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
12.3
2%
6.1
US
Pfizer Inc
NYSE:PFE
19.7
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
20.1
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Morepen Laboratories Ltd
NSE:MOREPENLAB
Average EV/EBITDA: 43
15.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.5
34%
1
US
Johnson & Johnson
NYSE:JNJ
14.8
2%
7.4
CH
Roche Holding AG
SIX:ROG
12.8
5%
2.6
US
Merck & Co Inc
NYSE:MRK
10.2
7%
1.5
UK
AstraZeneca PLC
LSE:AZN
15.2
10%
1.5
CH
Novartis AG
SIX:NOVN
12.8
6%
2.1
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8.6
1%
8.6
US
Pfizer Inc
NYSE:PFE
7.4
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.1
-9%
N/A